History & Overview Annual Report President's Pages Center News Community Affairs Code of Conduct
Make a Gift Cycle for Survival Fred's Team Yankees Universe Fund Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck CELEBRATIONS
Press Releases In the News Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days IS Careers Job Search & Apply Online

Microsimulation Modeling Effective Health Policies for Colorectal Cancer

MSKCC Principal Investigator
Ann Zauber, PhD


Study Objective

To develop microsimulation population based models for the natural history of colorectal cancer; to determine the optimal best case strategies to reduce the CRC mortality rates in the population; and to use these models to inform health policy

Why Is this Study Important?

Even though we have effective strategies to reduce colorectal cancer (CRC) mortality, CRC is the number two cause of cancer death in the United States. The difficulty is in getting these successful interventions implemented in the general population. The microsimulation modeling can provide guidance to health policy planners in choosing effective policies for intervention.

Who Is Conducting this Study?

The study is being conducted by our investigator, Ann Zauber, in collaboration with Erasmus MC University in Rotterdam. We are part of the Cancer Intervention and Surveillance Modeling Network of the National Cancer Institute.

Contact

Ann Zauber

Selected Publications

  • Vogelaar I, van Ballegooijen M, Schrag D, Boer R, Winawer SJ, Habbema JDF, Zauber AG. How much can current interventions reduce colorectal cancer mortality in the US? Mortality projections for scenarios of risk factor modification, screening and treatment. Cancer 2006;107:1624-1633.
  • Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2008;149:659-669 PMCID PMC2731975
  • Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Habbema JD. At what costs will screening with CT colonography be competitive? A cost-effectiveness approach. Int J Cancer. 2009 Mar 1;124(5):1161-8.
  • Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Winawer SJ, Habbema JDF. Individualizing colonoscopy screening by gender and race. Gastrointestinal Endoscopy. 2009 May 23. NIHMSID 129215
Bookmark and SharePrintEmail This Page